What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Randy D. Gascoyne mostly deals with Lymphoma, Diffuse large B-cell lymphoma, Pathology, Cancer research and Internal medicine. His Lymphoma study integrates concerns from other disciplines, such as Molecular biology and Survival analysis. His Diffuse large B-cell lymphoma research incorporates themes from Immunohistochemistry, Gene expression profiling and Rituximab.
His Pathology research integrates issues from Chromosomal translocation and Cytogenetics. Randy D. Gascoyne has included themes like Reed–Sternberg cell, Cyclin D2, Germinal center, Regulation of gene expression and STAT protein in his Cancer research study. His studies deal with areas such as Gastroenterology, Surgery and Oncology as well as Internal medicine.
His most cited work include:
- Circos: An information aesthetic for comparative genomics (5678 citations)
- Revised response criteria for malignant lymphoma (3306 citations)
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma (3077 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Lymphoma, Internal medicine, Diffuse large B-cell lymphoma, Cancer research and Pathology. His Lymphoma research is multidisciplinary, incorporating perspectives in Molecular biology, Cancer and Germinal center. Randy D. Gascoyne interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine.
His Oncology research includes elements of Survival rate, Clinical trial, Survival analysis and ABVD. Randy D. Gascoyne has researched Diffuse large B-cell lymphoma in several fields, including CHOP, BCL6 and Gene expression profiling. In his study, which falls under the umbrella issue of Cancer research, Cyclin D1 is strongly linked to Mantle cell lymphoma.
He most often published in these fields:
- Lymphoma (54.90%)
- Internal medicine (39.06%)
- Diffuse large B-cell lymphoma (35.67%)
What were the highlights of his more recent work (between 2016-2021)?
- Lymphoma (54.90%)
- Diffuse large B-cell lymphoma (35.67%)
- Cancer research (29.75%)
In recent papers he was focusing on the following fields of study:
Randy D. Gascoyne spends much of his time researching Lymphoma, Diffuse large B-cell lymphoma, Cancer research, Internal medicine and Oncology. The various areas that Randy D. Gascoyne examines in his Lymphoma study include Immunohistochemistry, BCL6, Gene, Somatic cell and Tumor microenvironment. His Diffuse large B-cell lymphoma research is included under the broader classification of Pathology.
His Cancer research research is multidisciplinary, relying on both Exome sequencing, Gene mutation, Mutation, Gene expression profiling and Germinal center. Internal medicine is frequently linked to Gastroenterology in his study. In his research, Venetoclax and Proportional hazards model is intimately related to International Prognostic Index, which falls under the overarching field of Oncology.
Between 2016 and 2021, his most popular works were:
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (524 citations)
- CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas (124 citations)
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma (117 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Lymphoma, Cancer research, Diffuse large B-cell lymphoma, Internal medicine and Gene. Randy D. Gascoyne mostly deals with International Prognostic Index in his studies of Lymphoma. His research in Cancer research intersects with topics in Exome sequencing, Gene mutation, Mutation, Cancer and Germinal center.
His Diffuse large B-cell lymphoma study combines topics from a wide range of disciplines, such as B-cell receptor, Molecular classification, Bruton's tyrosine kinase and Syk. His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine. Randy D. Gascoyne combines subjects such as Molecular biology, Gene rearrangement and Fluorescence in situ hybridization with his study of BCL6.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
